The Challenge

The Client, a US-based whole-person chronic condition management platform, sought to expand beyond its domestic market and establish a sustainable presence in the Middle East.

Despite having a clinically robust solution, they needed to refine their US value proposition, understand regional entry pathways, and determine the appropriate investment vehicle for international expansion. They also required guidance on payer engagement, cultural adaptation of mental health and chronic disease pathways, and strengthening their board with industry expertise.

The Client asked Emica to provide long-term strategic advisory support to shape their proposition, guide market entry, and accelerate commercial traction across the GCC.

---

Our Approach

• Refined the Client’s US value proposition to ensure clarity and differentiation before international expansion.
• Supported evaluation of strategic entry pathways, including investment vehicles and payer-partnering models.
• Strengthened the Client’s governance by helping them transition from financial advisors to sector-leading board members.
• Developed a GCC market entry strategy, including target operating model options and ecosystem engagement pathways.
• Facilitated cultural and clinical adaptation of chronic care and mental health pathways for regional applicability.
• Provided hands-on pitch preparation and market access, connecting the Client with leading health systems across Saudi Arabia.

---

Outcomes

• Strengthened the Client’s US board composition by identifying and securing an industry expert to join as a board member.
• Defined a clear, regionalised operating and market entry strategy tailored to the GCC’s payer landscape.
• Enabled culturally adapted chronic condition and mental health pathways aligned to regional needs and insurer expectations.
• Initiated active commercial discussions with leading Saudi healthcare systems, accelerating regional traction.